货号:GS40678
Suciraslimab is a human IgG1 kappa monoclonal antibody targeting CD22, a transmembrane protein expressed on mature B cells. It binds to CD22 to modulate B cell receptor signaling and is often developed as an antibody-drug conjugate (ADC) to deliver cytotoxic agents directly to B-cell malignancies. It is being investigated for the treatment of non-Hodgkin lymphoma and autoimmune diseases.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯